Gaps remain in EU nanotech risk assessments

EU risk assessments for nanomaterials are still inadequate and require further work, according to an opinion published on Wednesday by the scientific committee on emerging and newly identified health risks (Scenihr).

The full text of this article is only available to subscribers and free trialists. To login,please enter your email address and subscriber access code below.

Not a subscriber or free trialist? Why not take a free 14 day trial or subscribe today!

Having trouble logging in? Please contact our helpdesk

Back to top Back to top